Kraig Biocraft Laboratories (KBLB) Long-Term Deferred Tax (2014 - 2023)

Kraig Biocraft Laboratories (KBLB) has 8 years of Long-Term Deferred Tax data on file, last reported at $5.3 million in Q4 2023.

• For the quarter ending Q4 2023, Long-Term Deferred Tax rose 9.32% year-over-year to $5.3 million; the trailing twelve-month figure through Dec 2023 stood at $5.3 million (up 9.32% YoY), and the FY2023 full-year result was $5.3 million, up 9.32% from the prior year.
• Long-Term Deferred Tax climbed to $5.3 million in Q4 2023, from $4.9 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $5.3 million in Q4 2023 to a low of $3.4 million in Q4 2019.
• A 5-year average of $4.4 million and a median of $4.4 million in 2021 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax grew 16.1% in 2019 and gained 9.32% in 2023, its largest moves.
• Tracing KBLB's Long-Term Deferred Tax over 5 years: stood at $3.4 million in 2019, then climbed by 12.9% to $3.8 million in 2020, then advanced by 14.36% to $4.4 million in 2021, then climbed by 12.01% to $4.9 million in 2022, then increased by 9.32% to $5.3 million in 2023.
• Business Quant data shows KBLB's Long-Term Deferred Tax at $5.3 million in Q4 2023, $4.9 million in Q4 2022, and $4.4 million in Q4 2021.